Cell-sheet technology combined with a thienoindazole derivative small compound TD-198946 for cartilage regeneration

Biomaterials

Volumn 34, Issue 22, 2013, Pages 5581-5587

  Yano, Fumiko ^a   Hojo, Hironori ^a   Ohba, Shinsuke ^a   Saito, Taku ^b   Honnami, Muneki ^b   Mochizuki, Manabu ^b   Takato, Tsuyoshi ^b   Kawaguchi, Hiroshi ^b   Chung, Ung il ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Bone marrow stem cells; Cartilage tissue engineering; Cell sheet technology; Osteoarthritis

Indexed keywords

ARTICULAR CARTILAGE DEFECTS; BONE MARROW STEM CELLS; CARTILAGE TISSUE ENGINEERING; CHONDROGENIC DIFFERENTIATION; ENDOCHONDRAL OSSIFICATION; HUMAN MESENCHYMAL STEM CELLS; OSTEOARTHRITIS; TEMPERATURE-RESPONSIVE;

BODY FLUIDS; BONE; CARTILAGE; CYTOLOGY; DEFECTS; JOINTS (ANATOMY); MAMMALS; PATIENT TREATMENT; STEM CELLS; TISSUE; TRANSPLANTATION (SURGICAL);

SCAFFOLDS (BIOLOGY);

BIOMATERIAL; INDAZOLE DERIVATIVE; TD 198946; THIENOINDAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOTECHNOLOGY; CARTILAGE; CARTILAGE CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TISSUE ENGINEERING; TISSUE REGENERATION;

ANIMALS; BONE MARROW CELLS; CARTILAGE, ARTICULAR; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CHONDROCYTES; CHONDROGENESIS; DOGS; HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS; HUMANS; INDAZOLES; MICE; MICE, INBRED C57BL; REGENERATION; STEM CELLS;

MUS;

EID: 84877629858     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.04.008     Document Type: Article

References (32)

1. Doherty M. Risk factors for progression of knee osteoarthritis. Lancet 2001, 358:775-776.
2. Brittberg M., Lindahl A., Nilsson A., Ohlsson C., Isaksson O., Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. NEngl J Med 1994, 331:889-895.
3. Ochi M., Uchio Y., Kawasaki K., Wakitani S., Iwasa J. Transplantation of cartilage-like tissue made by tissue engineering in the treatment of cartilage defects of the knee. JBone Jt Surg Br 2002, 84:571-578.
4. Peterson L., Minas T., Brittberg M., Lindahl A. Treatment of osteochondritis dissecans of the knee with autologous chondrocyte transplantation: results at two to ten years. JBone Jt Surg Am 2003, 85-A(Suppl. 2):17-24.
5. von der Mark K., Gauss V., von der Mark H., Muller P. Relationship between cell shape and type of collagen synthesised as chondrocytes lose their cartilage phenotype in culture. Nature 1977, 267:531-532.
6. Yano F., Hojo H., Ohba S., Fukai A., Hosaka Y., Ikeda T., et al. Anovel disease-modifying osteoarthritis drug candidate targeting Runx1. Ann Rheum Dis 2013, 72:748-753.
7. Okano T., Yamada N., Sakai H., Sakurai Y. Anovel recovery system for cultured cells using plasma-treated polystyrene dishes grafted with poly(N-isopropylacrylamide). JBiomed Mater Res 1993, 27:1243-1251.
8. Obokata H., Yamato M., Tsuneda S., Okano T. Reproducible subcutaneous transplantation of cell sheets into recipient mice. Nat Protoc 2011, 6:1053-1059.
9. Ito S., Sato M., Yamato M., Mitani G., Kutsuna T., Nagai T., et al. Repair of articular cartilage defect with layered chondrocyte sheets and cultured synovial cells. Biomaterials 2012, 33:5278-5286.
10. Ebihara G., Sato M., Yamato M., Mitani G., Kutsuna T., Nagai T., et al. Cartilage repair in transplanted scaffold-free chondrocyte sheets using a minipig model. Biomaterials 2012, 33:3846-3851.
11. Nishida K., Yamato M., Hayashida Y., Watanabe K., Yamamoto K., Adachi E., et al. Corneal reconstruction with tissue-engineered cell sheets composed of autologous oral mucosal epithelium. NEngl J Med 2004, 351:1187-1196.
12. Gosset M., Berenbaum F., Thirion S., Jacques C. Primary culture and phenotyping of murine chondrocytes. Nat Protoc 2008, 3:1253-1260.
13. Cornish J., Gillespie M.T., Callon K.E., Horwood N.J., Moseley J.M., Reid I.R. Interleukin-18 is a novel mitogen of osteogenic and chondrogenic cells. Endocrinology 2003, 144:1194-1201.
14. Yano F., Kugimiya F., Ohba S., Ikeda T., Chikuda H., Ogasawara T., et al. The canonical Wnt signaling pathway promotes chondrocyte differentiation inaSox9-dependent manner. Biochem Biophys Res Commun 2005, 333:1300-1308.
15. Tsutsumi S., Shimazu A., Miyazaki K., Pan H., Koike C., Yoshida E., et al. Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem Biophys Res Commun 2001, 288:413-419.
16. Shah R.N., Shah N.A., Del Rosario Lim M.M., Hsieh C., Nuber G., Stupp S.I. Supramolecular design of self-assembling nanofibers for cartilage regeneration. Proc Natl Acad Sci U S A 2010, 107:3293-3298.
17. Ohba S., Ikeda T., Kugimiya F., Yano F., Lichtler A.C., Nakamura K., et al. Identification of a potent combination of osteogenic genes for bone regeneration using embryonic stem (ES) cell-based sensor. FASEB J 2007, 21:1777-1787.
18. Akiyama H., Fukumoto A., Shigeno C., Ito H., Mukai S., Hoshino T., et al. TAK-778, a novel synthetic 3-benzothiepin derivative, promotes chondrogenesis invitro and invivo. Biochem Biophys Res Commun 1999, 261:131-138.
19. Okada A., Shiomi T., Aoki Y., Fujiwara M. Phenytoin stimulates chondrogenic differentiation in mouse clonal chondrogenic EC cells, ATDC5. JToxicol Sci 2005, 30:145-156.
20. Nakamura Y., Takarada T., Kodama A., Hinoi E., Yoneda Y. Predominant promotion by tacrolimus of chondrogenic differentiation to proliferating chondrocytes. JPharmacol Sci 2009, 109:413-423.
21. Hojo H., Yano F., Ohba S., Igawa K., Nakajima K., Komiyama Y., et al. Identification of oxytetracycline as a chondrogenic compound using a cell-based screening system. JBone Miner Metab 2010, 28:627-633.
22. Noguchi K., Watanabe Y., Fuse T., Takizawa M. Anew chondrogenic differentiation initiator with the ability to up-regulate SOX trio expression. JPharmacol Sci 2010, 112:89-97.
23. Ochi M., Kawasaki K., Kataoka H., Uchio Y., Nishi H. AG-041R, a gastrin/CCK-B antagonist, stimulates chondrocyte proliferation and metabolism invitro. Biochem Biophys Res Commun 2001, 283:1118-1123.
24. Kitamura H., Kato A., Esaki T. AG-041R, a novel indoline-2-one derivative, induces systemic cartilage hyperplasia in rats. Eur J Pharmacol 2001, 418:225-230.
25. Okazaki M., Higuchi Y., Kitamura H. AG-041R stimulates cartilage matrix synthesis without promoting terminal differentiation in rat articular chondrocytes. Osteoarthr Cartil 2003, 11:122-132.
26. Nakanishi T., Kawasaki K., Uchio Y., Kataoka H., Terashima M., Ochi M. AG-041R, a cholecystokinin-B/gastrin receptor antagonist, stimulates the repair of osteochondral defect in rabbit model. Eur J Pharmacol 2002, 439:135-140.
27. Kitamura H., Okazaki M. AG-041R, a novel indoline-2-one derivative, stimulates chondrogenesis in a bipotent chondroprogenitor cell line CL-1. Osteoarthr Cartil 2005, 13:287-296.
28. Kaneshiro N., Sato M., Ishihara M., Mitani G., Sakai H., Mochida J. Bioengineered chondrocyte sheets may be potentially useful for the treatment of partial thickness defects of articular cartilage. Biochem Biophys Res Commun 2006, 349:723-731.
29. Mitani G., Sato M., Lee J.I., Kaneshiro N., Ishihara M., Ota N., et al. The properties of bioengineered chondrocyte sheets for cartilage regeneration. BMC Biotechnol 2009, 9:17.
30. Hunziker E.B. Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects. Osteoarthr Cartil 2002, 10:432-463.
31. Alford J.W., Cole B.J. Cartilage restoration, part 1: basic science, historical perspective, patient evaluation, and treatment options. Am J Sports Med 2005, 33:295-306.
32. Ohki T., Yamato M., Murakami D., Takagi R., Yang J., Namiki H., et al. Treatment of oesophageal ulcerations using endoscopic transplantation of tissue-engineered autologous oral mucosal epithelial cell sheets in a canine model. Gut 2006, 55:1704-1710.